Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $601.91 million
- Book Value:
- Revenue TTM:
- $268.64 million
- Operating Margin TTM:
- Gross Profit TTM:
- $104.27 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Terrascend Corp had its IPO on under the ticker symbol TRSSF.
The company operates in the Consumer Non-Cyclicals sector and Food & Drug Retailing industry. Terrascend Corp has a staff strength of 972 employees.
Shares of Terrascend Corp opened at $2.3 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.09 - $2.3, and closed at $2.19.
This is a -1.31% slip from the previous day's closing price.
A total volume of 765,421 shares were traded at the close of the day’s session.
In the last one week, shares of Terrascend Corp have increased by +26.36%.
Terrascend Corp's Key Ratios
Terrascend Corp has a market cap of $601.91 million, indicating a price to book ratio of 1.6515 and a price to sales ratio of 2.2913.
In the last 12-months Terrascend Corp’s revenue was $268.64 million with a gross profit of $104.27 million and an EBITDA of $10.05 million. The EBITDA ratio measures Terrascend Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Terrascend Corp’s operating margin was -4.73% while its return on assets stood at -0.91% with a return of equity of -73.94%.
In Q2, Terrascend Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 42.8%.
Terrascend Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-1.3 per share while it has a forward price to earnings multiple of 32.6797 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Terrascend Corp’s profitability.
Terrascend Corp stock is trading at a EV to sales ratio of 3.0309 and a EV to EBITDA ratio of -2.502. Its price to sales ratio in the trailing 12-months stood at 2.2913.
Terrascend Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $721.75 million
- Total Liabilities
- $133.49 million
- Operating Cash Flow
- Capital Expenditure
- $1.95 million
- Dividend Payout Ratio
Terrascend Corp ended 2023 with $721.75 million in total assets and $0 in total liabilities. Its intangible assets were valued at $721.75 million while shareholder equity stood at $293.63 million.
Terrascend Corp ended 2023 with $0 in deferred long-term liabilities, $133.49 million in other current liabilities, in common stock, $-653623000.00 in retained earnings and $99.95 million in goodwill. Its cash balance stood at $28.92 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $186.85 million.
Terrascend Corp’s total current assets stands at $106.63 million while long-term investments were $0 and short-term investments were $1.93 million. Its net receivables were $8.36 million compared to accounts payable of $50.84 million and inventory worth $54.02 million.
In 2023, Terrascend Corp's operating cash flow was $0 while its capital expenditure stood at $1.95 million.
Comparatively, Terrascend Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Terrascend Corp stock is currently trading at $2.19 per share. It touched a 52-week high of $2.5 and a 52-week low of $2.5. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $1.68 and 200-day moving average was $1.6 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 887.2% of the company’s stock are held by insiders while 536.5% are held by institutions.
Frequently Asked Questions About Terrascend Corp
Similar Industry Stocks (Food & Drug Retailing)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.